drugset / Trial / NCT03238352

A Study to Assess Efficacy of an Experimental Oral Rinse in Providing Long Term Relief From Dentinal Hypersensitivity

NCT03238352 ↗

Phase 2 Completed 89 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate the efficacy of an experimental oral rinse, containing 1.5% potassium oxalate (KOX) and 0 parts per million (ppm) fluoride in relieving dentine hypersensitivity (DH) after 8 weeks use compared with a placebo oral rinse and a commercialized fluoride oral rinse.

Timeline

Start
2017-08-07
Primary completion
2017-10-27
Completion
2017-10-27

Outcome

Met primary endpoint

registry Test Product (1.5% KOX, 0 Ppm Fluoride, pH 7) vs Negative Control (0.02% w/w Sodium Fluoride); p <0.0001; Difference of Least Square mean -1.22 NCT03238352 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium fluoride Unknown 0.02 % Oral

Indications